Mannheim, 5. April 2024. Ongoing global disruptions and increasingly complex supply chain networks present new challenges for supply chain executives in their daily business. At LogiPharma 2024, the world’s largest conference for the pharmaceutical and life science industry, Camelot will present approaches and solutions to address current and future challenges.
Due to persistent restrictions and disruptions in global supply chains, supply chain executives are tasked with ensuring the competitiveness of their companies by enhancing the resilience of their supply chains. On the other hand, there is the demand to provide patients with newly developed medications and therapies. This growing complexity of manufacturing and supplying new therapies requires new collaboration and coordination within supply chain management as well as logistics while maintaining high standards.
At LogiPharma 2024, we will showcase our tailored portfolio for the pharmaceutical industry to address disruptions and complexity:
Camelot and STADA Arzneimittel AG Live on Stage on April 16th, 12:50 PM
In this session, we will provide exclusive insights into our current supply chain project: Gerard Willemsen, Senior Director Global Supply Planning at STADA Arzneimittel AG, and Thomas Ebel, our Partner for Value Chain Strategy & Transformation, will present our joint case study “How to Drive Inventory Optimization in a Complex and Volatile Environment to Create Maximum Value in a Balanced Way.” In the context of current industry developments, they will share key measures and learnings from inventory optimization in the current market environment in generics, consumer health, and specialty:
Exclusive Masterclass “Navigating Supply Chains in Times of Rising Uncertainty and Disruptions – How to Respond” on April 16th, 2 PM
Modern PLM systems empower businesses to achieve product excellence in fast-paced markets by enhancing collaboration, agility and innovation.
Read how the Campaign Planner & Designer (CPD) helps you to manage supply chain variability.
© Camelot Management Consultants, Part of Accenture